MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) is stepping into one of biotech’s most important global spotlights, with its top ...
COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones.
Capital Link is hosting a series of online Company Presentations, during which the Senior Management teams of leading publicly listed maritime companies will present their business development, ...
Q1 2026 Earnings Call Transcript January 8, 2026 Simulations Plus, Inc. misses on earnings expectations. Reported EPS is ...
Biopharma enters 2026 amid continuing scientific progress and accelerating deal activity, yet its business model is under pressure across every facet of the value chain. Investors are taking note: ...
Bob Goodson Joins Accruit as Director, Business Development, Expanding Footprint in Agribusiness and Land Veteran Sales Leader Brings Decades of Experience Supporting Farm, Ranch, and Recreational ...